Clinical trial

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

NCT00637065

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE4

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2008-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Interstitial Lung Diseaseunresolved

Idiopathic Pulmonary Fibrosisunresolved

Nonspecific Interstitial Pneumoniaunresolved

Interventions

BosentanDRUG · verified · RxNorm: bosentan

PlaceboDRUG

Sponsors & collaborators

Royal Brompton & Harefield NHS Foundation Trustlead sponsor

Actelioncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00637065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.